Search Results - "Belviso, Nick"

Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program by Thompson, Mattea Tan, Virginia, Devonshire, Nick, Belviso, Melissa, Gillen, Engineer, Noella, Shen, Changyu, Reedie, Scott

“…•Dimethyl fumarate (DMF) is a disease-modifying therapy for multiple sclerosis (MS).•90.4% of patients (N = 6848) were adherent to DMF in this Canadian support…”
Get full text

Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM by Williams, Mitzi J., Amezcua, Lilyana, Chinea, Angel, Cohan, Stanley, Okai, Annette, Okuda, Darin T., Vargas, Wendy, Belviso, Nick, Božin, Ivan, Jiang, Xiaotong, Lewin, James B., Lyons, Jennifer, Shen, Changyu, England, Sarah M., Grimes, Nydjie

“…Introduction Multiple sclerosis (MS) clinical trials have included low numbers of patients from racial and ethnic minority populations; therefore, it is…”
Get full text

137 Impact of absolute lymphocyte count (ALC) frequency on detection of dimethyl fumarate–associated lymphopenia by Brownlee, Wallace, Hadipour-Rahimabadi, Shooka, Davies, Heather, Belviso, Nick, Shen, Changyu, Kapadia, Shivani, Levin, Seth, Li, Hanyue

“…IntroductionLymphopenia is a known adverse event of dimethyl fumarate (DMF) with treatment dis- continuation recommended for patients with severe prolonged (≥6…”
Get full text

Processing speed test: Results from a Japanese normative sample of healthy participants compared with a US normative sample by Niino, Masaaki, Miyazaki, Yusei, Altincatal, Arman, Belviso, Nick, Kanda, Michihiro, Chinen, Ichino, Edwards, Michael, de Moor, Carl, Williams, James R., Rao, Stephen M.

“…The Processing Speed Test (PST), a validated iPad®-based cognitive screening test for MS, has been applied to the cognitive assessment of Japanese MS patients…”
Get full text

Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab by Nicholas, Jacqueline, Belviso, Nick, Banerjee, Geentanjoli, Geremakis, Caroline, Avila, Robin, Bodhinathan, Karthik

Get full text